【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%，份额增加1.18亿份

证券之星10-31

证券之星消息，10月30日，广发中证香港创新药ETF(QDII)基金（513120）跌3.45%，成交额17.32亿元。当日份额增加了1.18亿份，最新份额为90.06亿份，近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-17.11%，近一个月超额回报为-0.99%，管理人为广发基金公司，基金经理为刘杰。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2479606447?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-31 06:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479606447","market":"sh","top_or_hot":-1,"title":"【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%，份额增加1.18亿份","media":"证券之星","content":"<html><body><p>证券之星消息，10月30日，广发中证香港创新药ETF(QDII)基金（513120）跌3.45%，成交额17.32亿元。当日份额增加了1.18亿份，最新份额为90.06亿份，近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-17.11%，近一个月超额回报为-0.99%，管理人为广发基金公司，基金经理为刘杰。</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%，份额增加1.18亿份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%，份额增加1.18亿份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-31 06:30 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2024103100008409.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，10月30日，广发中证香港创新药ETF(QDII)基金（513120）跌3.45%，成交额17.32亿元。当日份额增加了1.18亿份，最新份额为90.06亿份，近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港...</p>\n\n<a href=\"https://stock.stockstar.com/RB2024103100008409.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"515120","symbol_name":"创新药ETF","start_time":0,"source_url":"https://stock.stockstar.com/RB2024103100008409.shtml","article_id":"2479606447","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479606447","pubTimestamp":1730327449,"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，10月30日，广发中证香港创新药ETF(QDII)基金（513120）跌3.45%，成交额17.32亿元。当日份额增加了1.18亿份，最新份额为90.06亿份，近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-17.11%，近一个月超额回报为-0.99%，管理人为广发基金公司，基金经理为刘杰。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"515120":"创新药ETF"},"translate_title":"[ETF Trends] On October 30, the GF CSI Hong Kong Innovative Drug ETF (QDII) fell 3.45%, and its share increased by 118 million shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"515120":1},"content_text":"证券之星消息，10月30日，广发中证香港创新药ETF(QDII)基金（513120）跌3.45%，成交额17.32亿元。当日份额增加了1.18亿份，最新份额为90.06亿份，近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-17.11%，近一个月超额回报为-0.99%，管理人为广发基金公司，基金经理为刘杰。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479606447"}